NCT04053062 2024-01-05LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate CancerBioray LaboratoriesPhase 1 Suspended12 enrolled
NCT02814669 2019-09-24Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway InhibitorHoffmann-La RochePhase 1 Completed45 enrolled